Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
VORAPAXAR
(2014)
Small molecule
Unknown
Unknown
Approved
Thrombosis
VORAPAXAR
×
Maximum Phase:
4
First Approval:
2014
UNII:
ZCE93644N2
Molecule Type:
Small molecule
Molecular Formula:
C29H33FN2O4
Molecular Weight:
492.59
AlogP:
5.63
PSA:
77.52
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OLAPARIB
(2014)
Small molecule
PARP 1, 2 and 3 inhibitor
ORAL
Approved
Neoplasms; Ovarian Neoplasms
OLAPARIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
WOH1JD9AR8
Molecule Type:
Small molecule
Molecular Formula:
C24H23FN4O3
Molecular Weight:
434.47
AlogP:
2.35
PSA:
86.37
HBD:
1.0
HBA:
#RotB:
4.0
Source:
OLODATEROL
(2014)
Small molecule
Unknown
Unknown
Approved
Lung Diseases, Obstructive
OLODATEROL
×
Maximum Phase:
4
First Approval:
2014
UNII:
VD2YSN1AFD
Molecule Type:
Small molecule
Molecular Formula:
C21H26N2O5
Molecular Weight:
386.45
AlogP:
2.38
PSA:
100.05
HBD:
4.0
HBA:
#RotB:
7.0
Source:
TEDIZOLID PHOSPHATE
(2014)
Small molecule
Bacterial 70S ribosome inhibitor
INTRAVENOUS; ORAL
Approved
Unknown
TEDIZOLID PHOSPHATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
O7DRJ6R4DW
Molecule Type:
Small molecule
Molecular Formula:
C17H16FN6O6P
Molecular Weight:
450.32
AlogP:
1.51
PSA:
152.79
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ELIGLUSTAT
(2014)
Small molecule
Unknown
Unknown
Approved
Unknown
ELIGLUSTAT
×
Maximum Phase:
4
First Approval:
2014
UNII:
DR40J4WA67
Molecule Type:
Small molecule
Molecular Formula:
C23H36N2O4
Molecular Weight:
404.55
AlogP:
3.43
PSA:
71.03
HBD:
2.0
HBA:
#RotB:
11.0
Source:
CEFTOLOZANE SULFATE
(2014)
Small molecule
Bacterial penicillin-binding protein inhibitor
Unknown
Approved
Intraabdominal Infections; Urinary Tract Infections
CEFTOLOZANE SULFATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
7R247U84HY
Molecule Type:
Small molecule
Molecular Formula:
C23H32N12O12S3
Molecular Weight:
764.78
AlogP:
-3.9
PSA:
302.21
HBD:
7.0
HBA:
#RotB:
12.0
Source:
ELIGLUSTAT TARTRATE
(2014)
Small molecule
Ceramide glucosyltransferase inhibitor
ORAL
Approved
Gaucher Disease
ELIGLUSTAT TARTRATE
×
Maximum Phase:
4
First Approval:
2014
UNII:
N0493335P3
Molecule Type:
Small molecule
Molecular Formula:
C50H78N4O14
Molecular Weight:
959.19
AlogP:
3.43
PSA:
71.03
HBD:
2.0
HBA:
#RotB:
11.0
Source:
IDELALISIB
(2014)
Small molecule
PI3-kinase p110-delta subunit inhibitor
ORAL
Approved
Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Neoplasms
IDELALISIB
×
Maximum Phase:
4
First Approval:
2014
UNII:
YG57I8T5M0
Molecule Type:
Small molecule
Molecular Formula:
C22H18FN7O
Molecular Weight:
415.43
AlogP:
3.75
PSA:
101.38
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TENOFOVIR ALAFENAMIDE FUMARATE
(2015)
Small molecule
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
ORAL
Approved
HIV Infections; Hepatitis B, Chronic
TENOFOVIR ALAFENAMIDE FUMARATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
FWF6Q91TZO
Molecule Type:
Small molecule
Molecular Formula:
C46H62N12O14P2
Molecular Weight:
1069.02
AlogP:
2.97
PSA:
143.48
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ALECTINIB
(2015)
Small molecule
Unknown
Unknown
Approved
Neoplasms
ALECTINIB
×
Maximum Phase:
4
First Approval:
2015
UNII:
LIJ4CT1Z3Y
Molecule Type:
Small molecule
Molecular Formula:
C30H34N4O2
Molecular Weight:
482.63
AlogP:
4.77
PSA:
72.36
HBD:
1.0
HBA:
#RotB:
3.0
Source:
CARIPRAZINE HYDROCHLORIDE
(2015)
Small molecule
Dopamine D2 receptor modulator
ORAL
Approved
Bipolar Disorder; Schizophrenia
CARIPRAZINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
KQD7C255YG
Molecule Type:
Small molecule
Molecular Formula:
C21H33Cl3N4O
Molecular Weight:
463.88
AlogP:
4.34
PSA:
38.82
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SONIDEGIB PHOSPHATE
(2015)
Small molecule
Smoothened homolog inhibitor
ORAL
Approved
Carcinoma, Basal Cell
SONIDEGIB PHOSPHATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
W421AI34UW
Molecule Type:
Small molecule
Molecular Formula:
C26H32F3N3O11P2
Molecular Weight:
681.49
AlogP:
5.82
PSA:
63.69
HBD:
1.0
HBA:
#RotB:
5.0
Source:
AVIBACTAM
(2015)
Small molecule
Unknown
Unknown
Approved
Unknown
AVIBACTAM
×
Maximum Phase:
4
First Approval:
2015
UNII:
7352665165
Molecule Type:
Small molecule
Molecular Formula:
C7H11N3O6S
Molecular Weight:
265.25
AlogP:
-1.53
PSA:
130.24
HBD:
2.0
HBA:
#RotB:
3.0
Source:
DACLATASVIR DIHYDROCHLORIDE
(2015)
Small molecule
Nonstructural protein 5A inhibitor
Unknown
Approved
Hepatitis C, Chronic
DACLATASVIR DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
50ZO25C11D
Molecule Type:
Small molecule
Molecular Formula:
C40H52Cl2N8O6
Molecular Weight:
811.81
AlogP:
6.22
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
11.0
Source:
AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
(2015)
Small molecule
Unknown
Unknown
Approved
Unknown
AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ARIPIPRAZOLE LAUROXIL
(2015)
Small molecule
Dopamine D2 receptor partial agonist
INTRAMUSCULAR
Approved
Autistic Disorder; Bipolar Disorder; Depressive Disorder, Major; Schizophrenia; Tourette Syndrome
ARIPIPRAZOLE LAUROXIL
×
Maximum Phase:
4
First Approval:
2015
UNII:
B786J7A343
Molecule Type:
Small molecule
Molecular Formula:
C36H51Cl2N3O4
Molecular Weight:
660.73
AlogP:
8.68
PSA:
62.32
HBD:
0.0
HBA:
#RotB:
19.0
Source:
FLIBANSERIN
(2015)
Small molecule
Unknown
ORAL
Approved
Sexual Dysfunctions, Psychological
FLIBANSERIN
×
Maximum Phase:
4
First Approval:
2015
UNII:
37JK4STR6Z
Molecule Type:
Small molecule
Molecular Formula:
C20H21F3N4O
Molecular Weight:
390.41
AlogP:
3.17
PSA:
44.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ALECTINIB HYDROCHLORIDE
(2015)
Small molecule
ALK tyrosine kinase receptor inhibitor
ORAL
Approved
Carcinoma, Non-Small-Cell Lung
ALECTINIB HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
P9YY73LO6J
Molecule Type:
Small molecule
Molecular Formula:
C30H35ClN4O2
Molecular Weight:
519.09
AlogP:
4.77
PSA:
72.36
HBD:
1.0
HBA:
#RotB:
3.0
Source:
DACLATASVIR
(2015)
Small molecule
Unknown
Unknown
Approved
Virus Diseases
DACLATASVIR
×
Maximum Phase:
4
First Approval:
2015
UNII:
LI2427F9CI
Molecule Type:
Small molecule
Molecular Formula:
C40H50N8O6
Molecular Weight:
738.89
AlogP:
6.22
PSA:
174.64
HBD:
4.0
HBA:
#RotB:
11.0
Source:
EDOXABAN TOSYLATE
(2015)
Small molecule
Coagulation factor X inhibitor
ORAL
Approved
Atrial Fibrillation; Embolism; Pulmonary Embolism; Stroke; Venous Thrombosis
EDOXABAN TOSYLATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
32W99UE810
Molecule Type:
Small molecule
Molecular Formula:
C31H38ClN7O7S2
Molecular Weight:
720.27
AlogP:
1.29
PSA:
136.63
HBD:
3.0
HBA:
#RotB:
5.0
Source:
ELUXADOLINE
(2015)
Small molecule
Mu opioid receptor agonist
ORAL
Approved
Irritable Bowel Syndrome
ELUXADOLINE
×
Maximum Phase:
4
First Approval:
2015
UNII:
45TPJ4MBQ1
Molecule Type:
Small molecule
Molecular Formula:
C32H35N5O5
Molecular Weight:
569.66
AlogP:
4.16
PSA:
164.63
HBD:
4.0
HBA:
#RotB:
11.0
Source:
CANGRELOR
(2015)
Small molecule
Unknown
INTRAVENOUS
Approved
Thrombosis
CANGRELOR
×
Maximum Phase:
4
First Approval:
2015
UNII:
6AQ1Y404U7
Molecule Type:
Small molecule
Molecular Formula:
C17H25Cl2F3N5O12P3S2
Molecular Weight:
776.37
AlogP:
2.85
PSA:
255.91
HBD:
7.0
HBA:
#RotB:
15.0
Source:
SONIDEGIB
(2015)
Small molecule
Unknown
Unknown
Approved
Neoplasms
SONIDEGIB
×
Maximum Phase:
4
First Approval:
2015
UNII:
0RLU3VTK5M
Molecule Type:
Small molecule
Molecular Formula:
C26H26F3N3O3
Molecular Weight:
485.51
AlogP:
5.82
PSA:
63.69
HBD:
1.0
HBA:
#RotB:
5.0
Source:
URIDINE TRIACETATE
(2015)
Small molecule
Unknown
ORAL
Approved
Unknown
URIDINE TRIACETATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
2WP61F175M
Molecule Type:
Small molecule
Molecular Formula:
C15H18N2O9
Molecular Weight:
370.31
AlogP:
-1.14
PSA:
142.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LESINURAD
(2015)
Small molecule
Solute carrier family 22 member 12 inhibitor
ORAL
Approved
Gout; Hyperuricemia
LESINURAD
×
Maximum Phase:
4
First Approval:
2015
UNII:
09ERP08I3W
Molecule Type:
Small molecule
Molecular Formula:
C17H14BrN3O2S
Molecular Weight:
404.29
AlogP:
4.24
PSA:
68.01
HBD:
1.0
HBA:
#RotB:
5.0
Source:
OSIMERTINIB MESYLATE
(2015)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
Unknown
Approved
Carcinoma, Non-Small-Cell Lung
OSIMERTINIB MESYLATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
RDL94R2A16
Molecule Type:
Small molecule
Molecular Formula:
C29H37N7O5S
Molecular Weight:
595.73
AlogP:
4.51
PSA:
87.55
HBD:
2.0
HBA:
#RotB:
10.0
Source:
PANOBINOSTAT
(2015)
Small molecule
Unknown
Unknown
Approved
Neoplasms
PANOBINOSTAT
×
Maximum Phase:
4
First Approval:
2015
UNII:
9647FM7Y3Z
Molecule Type:
Small molecule
Molecular Formula:
C21H23N3O2
Molecular Weight:
349.43
AlogP:
3.33
PSA:
77.15
HBD:
4.0
HBA:
#RotB:
7.0
Source:
IVABRADINE
(2015)
Small molecule
Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker
ORAL
Approved
Cardiovascular Diseases
IVABRADINE
×
Maximum Phase:
4
First Approval:
2015
UNII:
3H48L0LPZQ
Molecule Type:
Small molecule
Molecular Formula:
C27H36N2O5
Molecular Weight:
468.59
AlogP:
3.31
PSA:
60.47
HBD:
0.0
HBA:
#RotB:
10.0
Source:
SACUBITRIL
(2015)
Small molecule
Neprilysin inhibitor
Unknown
Approved
Heart Failure
SACUBITRIL
×
Maximum Phase:
4
First Approval:
2015
UNII:
17ERJ0MKGI
Molecule Type:
Small molecule
Molecular Formula:
C24H29NO5
Molecular Weight:
411.5
AlogP:
3.84
PSA:
92.7
HBD:
2.0
HBA:
#RotB:
11.0
Source:
ROLAPITANT
(2015)
Small molecule
Unknown
Unknown
Approved
Nausea
ROLAPITANT
×
Maximum Phase:
4
First Approval:
2015
UNII:
NLE429IZUC
Molecule Type:
Small molecule
Molecular Formula:
C25H26F6N2O2
Molecular Weight:
500.48
AlogP:
5.73
PSA:
50.36
HBD:
2.0
HBA:
#RotB:
5.0
Source:
COBIMETINIB
(2015)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
Unknown
Approved
Neoplasms
COBIMETINIB
×
Maximum Phase:
4
First Approval:
2015
UNII:
ER29L26N1X
Molecule Type:
Small molecule
Molecular Formula:
C21H21F3IN3O2
Molecular Weight:
531.32
AlogP:
3.78
PSA:
64.6
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TIPIRACIL HYDROCHLORIDE
(2015)
Small molecule
Thymidine phosphorylase inhibitor
Unknown
Approved
Colorectal Neoplasms
TIPIRACIL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2015
UNII:
4H59KLQ0A4
Molecule Type:
Small molecule
Molecular Formula:
C9H12Cl2N4O2
Molecular Weight:
279.13
AlogP:
1.11
PSA:
93.33
HBD:
3.0
HBA:
#RotB:
2.0
Source:
COBIMETINIB FUMARATE
(2015)
Small molecule
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
ORAL
Approved
Melanoma
COBIMETINIB FUMARATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
6EXI96H8SV
Molecule Type:
Small molecule
Molecular Formula:
C46H46F6I2N6O8
Molecular Weight:
1178.7
AlogP:
3.78
PSA:
64.6
HBD:
3.0
HBA:
#RotB:
4.0
Source:
CARIPRAZINE
(2015)
Small molecule
Unknown
Unknown
Approved
Psychotic Disorders
CARIPRAZINE
×
Maximum Phase:
4
First Approval:
2015
UNII:
F6RJL8B278
Molecule Type:
Small molecule
Molecular Formula:
C21H32Cl2N4O
Molecular Weight:
427.42
AlogP:
4.34
PSA:
38.82
HBD:
1.0
HBA:
#RotB:
5.0
Source:
ISAVUCONAZONIUM SULFATE
(2015)
Small molecule
Lanosterol 14-alpha demethylase inhibitor
INTRAVENOUS; ORAL
Approved
Aspergillosis; Mucormycosis
ISAVUCONAZONIUM SULFATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
31Q44514JV
Molecule Type:
Small molecule
Molecular Formula:
C35H36F2N8O9S2
Molecular Weight:
814.85
AlogP:
4.58
PSA:
159.37
HBD:
2.0
HBA:
#RotB:
13.0
Source:
PANOBINOSTAT LACTATE
(2015)
Small molecule
Histone deacetylase inhibitor
ORAL
Approved
Multiple Myeloma
PANOBINOSTAT LACTATE
×
Maximum Phase:
4
First Approval:
2015
UNII:
HN0T99OO4V
Molecule Type:
Small molecule
Molecular Formula:
C24H29N3O5
Molecular Weight:
439.51
AlogP:
3.33
PSA:
77.15
HBD:
4.0
HBA:
#RotB:
7.0
Source:
1
2
…
64
65
66
67
68
69
70
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA